يعرض 1 - 10 نتائج من 31 نتيجة بحث عن '"Martin M. Dokter"', وقت الاستعلام: 1.00s تنقيح النتائج
  1. 1
  2. 2
  3. 3

    المساهمون: Groningen Kidney Center (GKC), Life Course Epidemiology (LCE), Cardiovascular Centre (CVC), Pharmaceutical Analysis, Critical care, Anesthesiology, Peri-operative and Emergency medicine (CAPE), Groningen Research Institute for Asthma and COPD (GRIAC), Biopharmaceuticals, Discovery, Design and Delivery (BDDD), Nanomedicine & Drug Targeting, Medicinal Chemistry and Bioanalysis (MCB), Restoring Organ Function by Means of Regenerative Medicine (REGENERATE)

    المصدر: European Journal of Heart Failure, 22(8), 1415-1423. Wiley
    European Journal of Heart Failure

    وصف الملف: application/pdf

  4. 4
  5. 5

    المساهمون: Cardiovascular Centre (CVC), Restoring Organ Function by Means of Regenerative Medicine (REGENERATE), Hubrecht Institute for Developmental Biology and Stem Cell Research, Physiology, ACS - Heart failure & arrhythmias

    المصدر: Circulation-Heart failure, 14(11):e008532. LIPPINCOTT WILLIAMS & WILKINS
    Circulation. Heart failure, 14(11). Lippincott Williams and Wilkins Ltd.
    Circulation. Heart failure, 14(11). Lippincott Williams and Wilkins
    Circulation. Heart Failure
    Eijgenraam, T R, Boogerd, C J, Stege, N M, Oliveira Nunes Teixeira, V, Dokter, M M, Schmidt, L E, Yin, X, Theofilatos, K, Mayr, M, van der Meer, P, van Rooij, E, van der Velden, J, Silljé, H H W & de Boer, R A 2021, ' Protein Aggregation Is an Early Manifestation of Phospholamban p.(Arg14del)-Related Cardiomyopathy : Development of PLN-R14del-Related Cardiomyopathy ', Circulation. Heart failure, vol. 14, no. 11, pp. e008532 . https://doi.org/10.1161/CIRCHEARTFAILURE.121.008532

    وصف الملف: application/pdf

  6. 6

    المساهمون: Cardiovascular Centre (CVC)

    المصدر: Cardiovascular Drugs and Therapy, 35, 953-963. SPRINGER
    Cardiovascular Drugs and Therapy
    Cardiovasc Drugs Ther

    وصف الملف: application/pdf

  7. 7

    المساهمون: Cardiovascular Centre (CVC)

    المصدر: Cardiovascular Research
    Cardiovascular Research, 117(9), 2108-2124. Oxford University Press

    وصف الملف: application/pdf

  8. 8

    المساهمون: BOZEC, Erwan, ERC CoG 818715, SECRETE‐HF - INCOMING, A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure - BIOSTAT-CHF - - EC:FP7:HEALTH2010-04-01 - 2015-03-31 - 242209 - VALID, University Medical Center Groningen [Groningen] (UMCG), Charité - UniversitätsMedizin = Charité - University Hospital [Berlin], Imperial College London - National Heart and Lung Institute, Robertson Centre for Biostatistics, University of Glasgow, University of Leicester, Stavanger University Hospital, Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), Ninewells Hospital and Medical School [Dundee], F. Hoffmann-La Roche [Basel], University of Brescia, Ospedale Policlinico San Martino [Genoa], Università degli studi di Genova = University of Genoa (UniGe), This study was funded by grant from theEuropean Research Council (ERC CoG 818715, SECRETE‐HF) and the European Commission (FP7‐242209‐BIOSTAT‐CHF).Canxia Shi is supported with a scholarship from the China Scholarship Council [CSC number: 201806170057]. Dr. de Boer is furthermore supported by the Dutch Heart Foundation [CVON DOSIS, grant 2014‐40, CVON SHE‐PREDICTS‐HF, grant 2017‐21, CVON RED‐CVD, grant 2017‐11, and CVON PREDICT2, grant 2018‐30], and the Innovational Research Incentives Scheme program of the Netherlands Organization for Scientific Research [NWO VIDI, grant 917·13·350], and by a grant from the Leducq Foundation [Cure PhosphoLambaN‐induced Cardiomyopathy (Cure‐PLaN)]. We would like to thank Roche Diagnostics for providing reagents to measure the tumour biomarkers (Dr. K van Lynden, Roche Diagnostics BV, the Netherlands)., European Project, European Project: 242209,EC:FP7:HEALTH,FP7-HEALTH-2009-single-stage,BIOSTAT-CHF(2010), Cardiovascular Centre (CVC), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Damage and Repair in Cancer Development and Cancer Treatment (DARE), Imperial College London, Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM), University of Genoa (UNIGE)

    المصدر: Journal of Internal Medicine
    Journal of Internal Medicine, 2020, 288 (2), pp.207-218. ⟨10.1111/joim.13053⟩
    Journal of Internal Medicine, 288(2), 207-218. Wiley
    Journal of Internal Medicine, Wiley, 2020, 288 (2), pp.207-218. ⟨10.1111/joim.13053⟩

    وصف الملف: application/pdf

  9. 9
  10. 10

    المساهمون: University Medical Center Groningen [Groningen] (UMCG), National Heart Centre Singapore (NHCS), Duke-NUS Medical School [Singapore], Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, Department of Cardiovascular Sciences [Leicester], University of Leicester, University of Dundee, Ninewells Hospital and Medical School [Dundee], University of Bergen (UiB), Stavanger University Hospital, National Heart and Lung Institute [London] (NHLI), Imperial College London-Royal Brompton and Harefield NHS Foundation Trust, University of Glasgow, Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM), Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), Berlin Institute of Health Center for Regenerative Therapies, German Centre for Cardiovascular Research (DZHK) partner site Berlin, Charité - UniversitätsMedizin = Charité - University Hospital [Berlin], University of Brescia, This work was supported by the Netherlands Cardiovascular Research Initiative: an initiative with support of the Dutch Heart Foundation and a grant from the European Commission [FP7-242209-BIOSTAT-CHF]. Reagents for NT-proBNP and GDF-15 were provided by Roche Diagnostics free of charge for the present study, European Project: 242209,EC:FP7:HEALTH,FP7-HEALTH-2009-single-stage,BIOSTAT-CHF(2010), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular Centre (CVC), Restoring Organ Function by Means of Regenerative Medicine (REGENERATE), BOZEC, Erwan, A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure - BIOSTAT-CHF - - EC:FP7:HEALTH2010-04-01 - 2015-03-31 - 242209 - VALID

    المصدر: Clinical Research in Cardiology
    Clinical Research in Cardiology, Springer Verlag, 2020, 109 (3), pp.331-338. ⟨10.1007/s00392-019-01513-y⟩
    Clinical Research in Cardiology, 109(3), 331-338. SPRINGER HEIDELBERG

    وصف الملف: application/pdf